Tara Gomes

PhD, MHSc

Scientist

Biography

Tara Gomes is an epidemiologist and Principal Investigator of the Ontario Drug Policy Research Network (ODPRN), a provincial network of researchers with expertise in pharmaceutical utilization, outcomes and policy who rapidly conduct research for drug decision-makers in Ontario and across Canada.  She holds a Canada Research Chair in Drug Policy Research and Evaluation, is a Scientist in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital and ICES, and is an assistant professor at the University of Toronto.  Her research is focused on pharmacoepidemiology, drug safety and drug policy research leveraging large, administrative databases, and she has published over 200 peer-reviewed articles and over 100 policy reports in this area.  Dr. Gomes also works closely with government regulators at the provincial and national level to develop evidence to inform policies related to opioid use disorder and opioid-related harm through the Ontario Opioid Drug Observatory.  In 2014, she was awarded the Institute for Public Administration of Canada’s Bronze Public Sector Leadership Award in Health and Education to recognize the impact of the ODPRN’s work.

Recent Publications

  1. Bozinoff, N, Men, S, Kurdyak, P, Selby, P, Gomes, T. Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper. JAMA Netw Open. 2022;5 (9):e2234168. doi: 10.1001/jamanetworkopen.2022.34168. PubMed PMID:36173629 .
  2. Gomes, T, Kitchen, S, Campbell, T, Murray, R, Leece, P, Kolla, G et al.. Responding to Ontario's Overdose Crisis in the Context of the COVID-19 Pandemic. Healthc Q. 2022;25 (2):7-12. doi: 10.12927/hcq.2022.26896. PubMed PMID:36153678 .
  3. Camacho, X, Zoega, H, Gomes, T, Schaffer, AL, Henry, D, Pearson, SA et al.. The association between psychostimulant use in pregnancy and adverse maternal and neonatal outcomes: results from a distributed analysis in two similar jurisdictions. Int J Epidemiol. 2022; :. doi: 10.1093/ije/dyac180. PubMed PMID:36135973 .
  4. Gomes, T, Kolla, G, McCormack, D, Sereda, A, Kitchen, S, Antoniou, T et al.. Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario. CMAJ. 2022;194 (36):E1233-E1242. doi: 10.1503/cmaj.220892. PubMed PMID:36122919 PubMed Central PMC9484622.
  5. Chin-Yee, N, Gomes, T, Tanuseputro, P, Talarico, R, Laupacis, A. Anticoagulant use and associated outcomes in older patients receiving home palliative care: a retrospective cohort study. CMAJ. 2022;194 (35):E1198-E1208. doi: 10.1503/cmaj.220919. PubMed PMID:36096505 PubMed Central PMC9477253.
  6. Shakeri, A, Hayes, KN, Gomes, T, Tadrous, M. Comparison of public and private payments for direct-acting antivirals (DAAs) across Canada. Can Liver J. 2021;4 (4):426-429. doi: 10.3138/canlivj-2020-0041. PubMed PMID:35989895 PubMed Central PMC9235118.
  7. Iacono, A, Campitelli, MA, Bronskill, SE, Hogan, DB, Iaboni, A, Maclagan, LC et al.. Correlates of Opioid Use Among Ontario Long-Term Care Residents and Variation by Pain Frequency and Intensity: A Cross-sectional Analysis. Drugs Aging. 2022; :. doi: 10.1007/s40266-022-00972-9. PubMed PMID:35976489 PubMed Central PMC9381389.
  8. Guan, Q, Men, S, Juurlink, DN, Bronskill, SE, Wunsch, H, Gomes, T et al.. Opioid Initiation and the Hazard of Falls or Fractures Among Older Adults with Varying Levels of Central Nervous System Depressant Burden. Drugs Aging. 2022;39 (9):729-738. doi: 10.1007/s40266-022-00970-x. PubMed PMID:35945484 .
  9. Kendzerska, T, Gomes, T, Malhotra, A, Gershon, AS, Povitz, M, McIsaac, DI et al.. Association of obstructive sleep apnea and opioids use on adverse health outcomes: A population study of health administrative data. PLoS One. 2022;17 (6):e0269112. doi: 10.1371/journal.pone.0269112. PubMed PMID:35763495 PubMed Central PMC9239451.
  10. McClean, AR, Law, MR, Harrison, M, Bansback, N, Gomes, T, Tadrous, M et al.. CMAJ. 2022;194 (25):E891-E896. doi: 10.1503/cmaj.211478-f. PubMed PMID:35760435 PubMed Central PMC9332920.
Search PubMed

Affiliations & Other Activities

  • Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
  • Scientist, Institute for Clinical Evaluative Sciences
  • Principal Investigator, Ontario Drug Policy Research Network